Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study
Bone Marrow Transplant. 2024 Jan;59(1):121-124.
doi: 10.1038/s41409-023-02096-z.
Epub 2023 Oct 6.